Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites

References

• Acton SE, Farrugia AJ, Astarita J, Mourão-Sá D, Jenkins RP, Nye E, Hooper S, van Blijswijk J, Rogers NC, Snelgrove KJ, et al. 2014. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature. 514(7523):498–502. doi:10.1038/nature13814.
   PubMed Web of Science ®Google Scholar
• Bedrosian I, Mick R, Xu S, Nisenbaum H, Faries M, Zhang P, Cohen PA, Koski G, Czerniecki BJ. 2003. Intranodal administration of peptide-pulsed mature dendritic cell vaccines results in superior CD8 + T-cell function in melanoma patients. J Clin Oncol. 21(20):3826–35.
   PubMed Web of Science ®Google Scholar
• Blaeschke F, Paul MC, Schuhmann MU, Rabsteyn A, Schroeder C, Casadei N, Matthes J, Mohr C, Lotfi R, Wagner B, et al. 2019. Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. Cytotherapy. 21(9):973–86. doi:10.1016/j.jcyt.2019.06.009.
   PubMed Web of Science ®Google Scholar
• Choudhury NJ, Kiyotani K, Yap KL, Campanile A, Antic T, Yew PY, Steinberg G, Park JH, Nakamura Y, O’Donnell PH, et al. 2016. Low T-cell receptor diversity, high somatic mutation burden, and high neoantigen load as predictors of clinical outcome in muscle-invasive bladder cancer. Eur Urol Focus. 2(4):445–52. doi:10.1016/j.euf.2015.09.007.
   PubMedGoogle Scholar
• Drerup JM, Liu Y, Padron AS, Murthy K, Hurez V, Zhang B, Curiel TJ. 2015. Immunotherapy for ovarian cancer. Curr Treat Options Oncol. 16(1):317. doi:10.1007/s11864-014-0317-1.
   PubMed Web of Science ®Google Scholar
• Durgeau A, Virk Y, Corgnac S, Mami-Chouaib F. 2018. Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy. Front Immunol. 9:14. doi:10.1007/s11864-014-0317-1.
   PubMed Web of Science ®Google Scholar
• Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. 2017. Trial watch: dendritic cell-based anticancer immunotherapy. Oncoimmunology. 6(7):e1328341.
   PubMed Web of Science ®Google Scholar
• Gilliet M, Kleinhans M, Lantelme E, Schadendorf D, Burg G, Nestle FO. 2003. Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood. 102(1):36–42.
   PubMed Web of Science ®Google Scholar
• Giudicelli V, Chaume D, Lefranc MP. 2005. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 33:D256–D261.
   PubMed Web of Science ®Google Scholar
• Johanns TM, Miller CA, Liu CJ, Perrin RJ, Bender D, Kobayashi DK, Campian JL, Chicoine MR, Dacey RG, Huang J, et al. 2019. Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastoma. Oncoimmunol. 8(4):e1561106. doi:10.1080/2162402X.2018.1561106.
   PubMed Web of Science ®Google Scholar
• Keskin DB, Anandappa AJ, Sun J, Tirosh I, Mathewson ND, Li S, Oliveira G, Giobbie-Hurder A, Felt K, Gjini E, et al. 2019. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature. 565(7738):234–39. doi:10.1038/s41586-018-0792-9.
   PubMed Web of Science ®Google Scholar
• Kissick HT. 2018. Is it possible to develop cancer vaccines to neoantigens, what are the major challenges, and how can these be overcome? Neoantigens as vaccine targets for cancer. Cold Spring Harb Perspect Biol. 10(11):a033704.
   PubMed Web of Science ®Google Scholar
• Kiyotani K, Chan HT, Nakamura Y. 2018. Immunopharmacogenomics towards personalized cancer immunotherapy targeting neoantigens. Cancer Sci. 109(3):542–49.
   PubMed Web of Science ®Google Scholar
• Kiyotani K, Park J-H, Inoue H, Husain A, Olugbile S, Zewde M, Nakamura Y, Vigneswaran WT. 2017. Integrated analysis of somatic mutations and immune microenvironment in malignant pleural mesothelioma. Oncoimmunol. 6(2):e1278330.
   PubMed Web of Science ®Google Scholar
• Lambert LA, Gibson GR, Maloney M, Durell B, Noelle RJ, Barth RJ. 2001. Intranodal immunization with tumor lysate-pulsed dendritic cells enhances protective antitumor immunity. Cancer Res. 61(2):641–46.
   PubMed Web of Science ®Google Scholar
• Liu XS, Mardis ER. 2017. Applications of immunogenomics to cancer. Cell. 168(4):600–12. doi:10.1016/j.cell.2017.01.014.
   PubMed Web of Science ®Google Scholar
• Martin SD, Brown SD, Wick DA, Nielsen JS, Kroeger DR, Twumasi-Boateng K, Holt RA, Nelson BH. 2016. Low mutation burden in ovarian cancer may limit the utility of neoantigen-targeted vaccines. PLoS One. 11(5):e0155189.
   PubMed Web of Science ®Google Scholar
• McGranahan N, Furness AJS, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, Jamal-Hanjani M, Wilson GA, Birkbak NJ, Hiley CT, et al. 2016. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science. 351(6280):1463–69. doi:10.1126/science.aaf1490.
   PubMed Web of Science ®Google Scholar
• Morse MA, Coleman RE, Akabani G, Niehaus N, Coleman D, Lyerly HK. 1999. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59(1):56–58.
   PubMed Web of Science ®Google Scholar
• Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med. 4(3):328–32.
   PubMed Web of Science ®Google Scholar
• Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, Zhang W, Luoma A, Giobbie-Hurder A, Peter L, et al. 2017. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature. 547(7662):217–21. doi:10.1038/nature22991.
   PubMed Web of Science ®Google Scholar
• Pokhriyal R, Hariprasad R, Kumar L, Hariprasad G. 2019. Chemotherapy resistance in advanced ovarian cancer patients. Biomark Cancer. 11:1179299X1986081.
   PubMedGoogle Scholar
• Ridolfi R, Riccobon A, Galassi R, Giorgetti G, Petrini M, Fiammenghi L, Stefanelli M, Ridolfi L, Moretti A, Migliori G, et al. 2004. Evaluation of in vivo labelled dendritic cell migration in cancer patients. J Transl Med. 2(1):27. doi:10.1186/1479-5876-2-27.
   PubMedGoogle Scholar
• Sahin U, Derhovanessian E, Miller M, Kloke B-P, Simon P, Löwer M, Bukur V, Tadmor AD, Luxemburger U, Schrörs B, et al. 2017. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 547(7662):222–26. doi:10.1038/nature23003.
   PubMed Web of Science ®Google Scholar
• Saxena M, Bhardwaj N. 2018. Re-emergence of dendritic cell vaccines for cancer treatment. Trend Cancer. 4(2):119–37.
   PubMed Web of Science ®Google Scholar
• Szolek A, Schubert B, Mohr C, Sturm M, Feldhahn M, Kohlbacher O. 2014. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics. 30(23):3310–16.
   PubMed Web of Science ®Google Scholar
• Yarchoan M, Johnson BA III, Lutz ER, Laheru DA, Jaffee EM. 2017. Targeting neoantigens to augment antitumor immunity. Nat Rev Cancer. 17(4):209–22. doi:10.1038/nrc.2016.154.
   PubMed Web of Science ®Google Scholar
• Yoshimura S, Tsunoda T, Osawa R, Harada M, Watanabe T, Hikichi T, Katsuda M, Miyazawa M, Tani M, Iwahashi M, et al. 2014. Identification of an HLA-A2-restricted epitope peptide derived from hypoxia-inducible protein 2 (HIG2). PLoS One. 9(1):e85267. doi:10.1371/journal.pone.0085267.
   PubMed Web of Science ®Google Scholar
• Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y-C, Zheng Z, Pasetto A, Langhan M, Shelton T, Prickett T, et al. 2018. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 24(6):724–30. doi:10.1038/s41591-018-0040-8.
   PubMed Web of Science ®Google Scholar
• Zamora AE, Crawford JC, Allen EK, Guo XZJ, Bakke J, Carter RA, Abdelsamed HA, Moustaki A, Li Y, Chang T-C, et al. 2019. Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8 + T cell responses. Sci Transl Med. 11(498):eaat8549. doi:10.1126/scitranslmed.aat8549.
   PubMed Web of Science ®Google Scholar